Member Info for stephen11

Thanks for the reply baserite,

I hope you are correct.

GLA.

I am relatively new to KOD and am really pleased to have got in at 0.21 and 0.24. Also happy for the long-term holders who have been on a bit of a rollercoaster and are now reaping the rewards.

I am looking to hold this share for the medium to long-term and was just wanting to ask a question regarding extraction timescales, to those who have more knowledge of the mining industry.

When? as a rough estimate will Kodal start physically extraditing lithium, after all the necessary licence fees and authorisations are received? Maybe this has been mentioned in previous communication?

6 months, 1 year?...longer, or what is the industry average?

GLA.

Great informative posts from Pacman, Preefty, Imphobe, Swerves, and BigAl tonight,

Don't let the derampers win. Great that you all see the short, medium-long term potential of this stock!

Good times ahead!

Preefty

The post on the fake accounts is a good one. It probably accounts for around 20% of this board (and that's being conservative). Fortunately, they mostly appear highlighted by green boxes, for me anyway. I suggest others make similar use of the filter button.

Lol....

GLA long term holders.

Stopped @typo

I hear you PinkInc,

I have stop posting for the same reason. It's a shame as some posters share informative, well researched information.

GLA.

https://www.lse.co.uk/rns/GDR/investor-presentation-5vonjs2o7tx3ftr.html

The speculation regarding the date of the next update prompted me to look at the RNS info from last year, though I'm not sure it's predictive of this year (that would be the gamblers fallacy)!

An investor webinar was announced (in the RNS above) to take place on June 12th 2020 last year. I might email Walbrook to ask if one is going to take place this year.

I will keep this board updated on any response.

GLA.

And please don't underestimate the effect that negative sentiment could be having on this share!

Companies can also reinvest profit from sales revenue.

Thanks for all the informative posts tonight.

Let's hope FDA will fall soon to place the last piece in the jigsaw.

GLA

Incorrect Maestro

CASH for around 8 months at a burn rate of 400,000 announced at the last presentation...and high stock levels....as you well know.

Don't start all this again!

We don't know if we have had sales or not. All we know is we have no declared sales. The rest is all speculation.

Stars

Interesting thread...thankyou to yourself and other posters. The price is listed on your link as 1200. I don't think it is a pound £ sign prior to the price figure. Could this be in Indian currency?

If so, how much is 1200 in Indian currency?

The state of the market; today, tomorrow and in the future is very hard to predict.

I'm sticking with a few recovery stocks, gold, diagnostics, and some lithium interests ATM.

Might be wrong.

FAO Increase

https://punctuationmarks.org/

It's a disappointing day for GDR, although the whole market is also a bloodbath today. 25 of the 32 AIM listed stocks in my watchlist are in the red or have stayed the same.

Unfortunately, i'm not one of the lucky ones invested in GAL....60% up over 2 days....nice if you can get it!

GLA and let's hope for better tomorrow.

This share is reminiscent of the game show "TIPPING POINT". Anyone of the deals, some, or all could come to fruition and create an AVALANCHE of cash. Maybe some don't have the patience to delay gratification? Make up your own mind.

1/ Genedrive 96-SARS-COV-2kit
- Huge worldwide potential
- 97.6% sensitivity and 98.2% specificity, compared to poor lateral flow test performance (sometimes as high as 50% false positives)
- Agreement with BC started 28th Jan 2021. Sales will materialise, though lead times and sales cycles should be considered
- Regulatory approval for Thailand and Senegal
- FDA frustrating, though the pace of approvals is accelerating

2/ Pathogen Detection (Bioplex): supplier to US military
- Development contract worth owner 10 million
- 500 kits over 3 years
- Partnership with MountainHorse: this will help develop a broader customer base

3/ Antibiotic induced hearing loss test
- World first
- Worldwide neo-natal hearing loss market worth 35-50 million annually (very niche market)
- Launch summer 2021 to UK and Ireland. Worldwide potential thereafter
- 100% accuracy in testing

4/ World first decentralised qualitative molecular HCV test
- Routes to market impacted by COVID
- Good medium to long-term potential
- High efficacy in a recent peer reviewed study

5/ Listed on the PHE chosen contractors list
- Potential for a share of the 3 billion budgeted future spend

6/ Regulatory approval for Indian market
- High test efficacy; 100% specificity and 100% sensitivity
- Access to a market equivalent to 17.7% of the total world population
- Divoc already in place
- Other contacts also being sourced

In Development

1/ Genedrive Saliva Test
- 15/20 minute rapid turnover
- Target market: schools/offices/travel etc.
- High accuracy unlike lateral flow tests

2/ Point of care test for tuberculosis
- On hold due to COVID, though good future potential for 2022/2023.

Other important points
- Healthy cash to burn ratio
- High stock levels to fulfil orders
- European ministry of health opportunity. Potential for a low double digit millions of pound order to be delivered in a short period of time

Good luck all

Increase

Are you a robot?

Good find PinkInc

Sales welcome in all continents.

GLA.

KOD is also worth checking out. I've shares here and in KOD. Also looking to take a position in SAV next month.

It's easy to see were the money will be as former gold mining companies are moving into lithium mining. It's going to be a necessity with this new carbon neutral policy rather around the EU and UK.

Good to see you back in Dave77...what prompted you to rejoin the rollercoaster?

Ps...BigBench...looks like the tea lady has also been telling her friends!

Lol.

Great to see!